Popular bowel drug pulled off the market

loading...
WASHINGTON – The maker of a popular new treatment for women’s irritable bowel syndrome pulled the drug Lotronex off the market Tuesday after it was linked to a growing number of deaths and hospitalizations. The withdrawal by Glaxo Wellcome Inc. comes just nine months after…
Sign in or Subscribe to view this content.

WASHINGTON – The maker of a popular new treatment for women’s irritable bowel syndrome pulled the drug Lotronex off the market Tuesday after it was linked to a growing number of deaths and hospitalizations.

The withdrawal by Glaxo Wellcome Inc. comes just nine months after Lotronex began selling with great fanfare.

The problem: Lotronex can cause severe side effects, including a life-threatening intestinal inflammation called ischemic colitis.


Have feedback? Want to know more? Send us ideas for follow-up stories.

comments for this post are closed

By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.